Publications scientifiques

Une forte valorisation scientifique de nos études attestée par nos publications

PCN24 clinical outcomes and health care resource utilisation of patients receiving lapatinib for breast cancer in france: the laps study (lapatinib atu parcours de soins)

Perrocheau G, Tehard B, Terpereau A, Doussaint J, Campone M.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Twelfth Annual European Congress. Paris

Validation of the Asthma Control Test questionnaire in a North African population.

El Hasnaoui A, Martin J, Salhi H, Doble A.

Respir Med. 2009 Dec;103 Suppl 2:S30-7.

Control of asthma in the Maghreb: results of the AIRMAG study.

Benkheder A, Bouacha H, Nafti S, Taright S, El Ftouh M, Yassine N, Fakhfakh H, Ali-Khoudja M, Texier N, El Hasnaoui A.

Respir Med. 2009 Dec;103 Suppl 2:S12-20.

Paediatric asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study.

El Ftouh M, Yassine N, Benkheder A, Bouacha H, Nafti S, Taright S, Fakhfakh H, Ali-Khoudja M, Texier N, El Hasnaoui A.

Respir Med. 2009 Dec;103 Suppl 2:S21-9.

Prevalence of asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study.

Nafti S, Taright S, El Ftouh M, Yassine N, Benkheder A, Bouacha H, Fakhfakh H, Ali-Khoudja M, Texier N, El Hasnaoui A.

Respir Med. 2009 Dec;103 Suppl 2:S2-11.

Biosimilars: The french policy.

Schück S, Texier N.

Int J Risk Saf Med. 2009;21(1-2):41-5.

General practice-based intervention for suspecting and detecting dementia in France: A cluster randomized controlled trial1

Rondeau V, Allain H, Backchine S, Bonet P, Brudon F, Chauplannaz G, Dubois B, Gallarda T, Lepine JP, Pasquier F, Pouchain D, Ritchie K, Robert P, Touchon J, Vellas B, Vercelletto M, Verny M, Carcaillon L, Duveau F, Millet V, Tonelli I, Dartigues J.

Dementia

Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study.

Crochard A, El Hasnaoui A, Pouchain D, Huas D, Arnulf I, Krieger J, Lainey E, Le Jeunne P, Leger D, Schuck S, Texier N, Tison F, Montplaisir J.

Mov Disord. 2007 Apr 30;22(6):791-7; quiz 907.

Factors determining treatment strategies for patients with benign prostatic hyperplasia. The DUO study

Fourcade RO, Picot MC, Gaudin AF, Texier N, Slama A.

Presse Med. 2007 May;36(5 Pt 1):755-63. French.

Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting.

Allain H, Schück S, Nachit-Ouinekh F, Plouin P, Brunon AM, Boulliat J, Mercier F, Slama A, Baulac M, El Hasnaoui A.

Seizure. 2007 Mar;16(2):173-84.

Typology of asthma patients who stop using controller therapy: a survey in general practice

Laforest L, Ritleng C, Pribil C, El Hasnaoui A, Schück S, Liesl O, Van Ganse E.

European Respiratory Society Annual Congress. Stockholm.

« EXACO »: four year follow-up of exacerbations in a cohort of patients with COPD

Tillie-Leblond I, Masure F; pour le groupe EXACO.

Rev Mal Respir. 2006 Sep;23(4 Pt 1):377-84. French.

Management of patients with benign prostatic hyperplasia by urologists: the DUO study

Fourcade RO, Picot MC, Gaudin AF, Texier N, Slama A.

Ann Urol (Paris). 2006 Nov;40 Suppl 3:S58-63. French.

The IMAGINE study

Touchon J, Dartigues JF, Schück S, Tonelli I.

Psychogeriatrics. 2006;6(s1):S8‑9

NOEMIE: an epidemiological study of migraine at work: results from 17 occupational health centres

Lantéri-Minet M, Allain H, Nachit-Ouinekh F, Bentué-Ferrer D, Gilbert P, Schück S, El Hasnaoui A; Comité d’Orientation National.

Rev Neurol (Paris). 2004 Oct;160(10):928-34. French.